Aaron Kesselheim (2009 AWardee) in "Drugmakers Help Turn Patients With Rare Diseases Into D.C. Lobbyists" in Kaiser Health News, April 10, 2017, in "RPT-The cost of cancer: new drugs show success at a steep price" in Reuters, April 3, 2017 and in "Critics cast doubt on pharmaceutical industry partnerships with advocacy groups" in Healthcare Finance, April 10, 2017.
News Source:
Date:
Monday, April 10, 2017
Investigator: